Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Chronic Plaque Psoriasis After Biologic Failure
NCT01200264Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Sep 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in psoriasis, sponsored by Duke University. Planned start Sep 2010; status: withdrawn.
02
Drugs
apremilast
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT01200264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200264.